Effects of exercise on sleep in neurodegenerative disease
- PMID: 32243913
- PMCID: PMC7497904
- DOI: 10.1016/j.nbd.2020.104859
Effects of exercise on sleep in neurodegenerative disease
Abstract
As the population ages, the incidence and prevalence of neurodegenerative disorders will continue to increase. Persons with neurodegenerative disease frequently experience sleep disorders, which not only affect quality of life, but potentially accelerate progression of the disease. Unfortunately, pharmacological interventions are often futile or have adverse effects. Therefore, investigation of non-pharmacological interventions has the potential to expand the treatment landscape for these disorders. The last decade has observed increasing recognition of the beneficial role of exercise in brain diseases, and neurodegenerative disorders in particular. In this review, we will focus on the therapeutic role of exercise for sleep dysfunction in four neurodegenerative diseases, namely Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Available data suggest that exercise may have the potential to improve sleep disorders and attenuate neurodegeneration, particularly in Alzheimer's disease and Parkinson's disease. However, additional research is required in order to understand the most effective exercise therapy for these indications; the best way to monitor the response to interventions; the influence of exercise on sleep dysfunction in Huntington's disease and amyotrophic lateral sclerosis; and the mechanisms underlying exercise-induced sleep modifications.
Keywords: Amyotrophic lateral sclerosis; Exercise: Alzheimer's disease; Huntington's disease; Parkinson's disease; Sleep.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.Eur J Neurosci. 2024 Oct;60(8):6057-6090. doi: 10.1111/ejn.16541. Epub 2024 Sep 19. Eur J Neurosci. 2024. PMID: 39297377 Review.
-
microRNAs and Neurodegenerative Diseases.Adv Exp Med Biol. 2015;888:85-105. doi: 10.1007/978-3-319-22671-2_6. Adv Exp Med Biol. 2015. PMID: 26663180 Review.
-
ADSC therapy in neurodegenerative disorders.Cell Transplant. 2014;23(4-5):549-57. doi: 10.3727/096368914X678445. Cell Transplant. 2014. PMID: 24816450 Review.
-
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.Mitochondrion. 2023 Jul;71:83-92. doi: 10.1016/j.mito.2023.05.007. Epub 2023 Jun 1. Mitochondrion. 2023. PMID: 37269968 Review.
-
Neural stem cell-based treatment for neurodegenerative diseases.Neuropathology. 2013 Oct;33(5):491-504. doi: 10.1111/neup.12020. Epub 2013 Feb 5. Neuropathology. 2013. PMID: 23384285 Review.
Cited by
-
Metabolic Disturbances Induced by Sleep Restriction as Potential Triggers for Alzheimer's Disease.Front Integr Neurosci. 2021 Sep 3;15:722523. doi: 10.3389/fnint.2021.722523. eCollection 2021. Front Integr Neurosci. 2021. PMID: 34539357 Free PMC article. Review.
-
The Beneficial Role of Exercise on Treating Alzheimer's Disease by Inhibiting β-Amyloid Peptide.Mol Neurobiol. 2021 Nov;58(11):5890-5906. doi: 10.1007/s12035-021-02514-7. Epub 2021 Aug 20. Mol Neurobiol. 2021. PMID: 34415486 Review.
-
Effects of exercise on sleep in patients with epilepsy: A systematic review.Epilepsy Behav Rep. 2024 May 9;26:100675. doi: 10.1016/j.ebr.2024.100675. eCollection 2024. Epilepsy Behav Rep. 2024. PMID: 38779424 Free PMC article. Review.
-
Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases.Front Aging Neurosci. 2023 May 26;15:1185671. doi: 10.3389/fnagi.2023.1185671. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37304072 Free PMC article. Review.
-
Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer's disease: an updated overview of nonpharmacological therapies.Mol Neurodegener. 2023 Apr 20;18(1):26. doi: 10.1186/s13024-023-00618-3. Mol Neurodegener. 2023. PMID: 37081555 Free PMC article. Review.
References
-
- Lopez OL, Dekosky ST. Clinical symptoms in Alzheimer’s disease. Handb Clin Neurol. 2008;89:207–216. - PubMed
-
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell. 1993;72(6):971–983. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials